Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
MedTech
J&J drops $400M to acquire novel stroke-reducing heart implant
J&J MedTech spent $400 million upfront to purchase Laminar, the developer of a device to help reduce the risk of stroke in people with afib.
Conor Hale
Nov 30, 2023 10:30am
RapidAI earns FDA nod for subdural hematoma-spotting AI
Nov 10, 2023 10:06am
First patient implanted with Onward BCI to restore arm function
Sep 27, 2023 10:57am
MedRhythms taps Curavit to study auditory stimulation technology
Sep 25, 2023 10:25am
Stroke tech maker Imperative Care completes long-planned reorg
Aug 11, 2023 12:45pm
RapidAI racks up $75M for stroke-spotting software
Jul 31, 2023 10:25am